This study is looking at how continuous glucose monitoring (CGM) with the Dexcom G6 device can help kidney transplant patients who have Type 2 diabetes and use insulin. Researchers want to see if using the Dexcom G6 helps you keep your blood sugar levels (glucose) in a healthy range (70-180 mg/dL) for more time. You might be able to join if you are 18 or older, had a kidney transplant within the last year with good kidney function (eGFR > 30 mL/min), have Type 2 diabetes and use insulin, and have home Wi-Fi. The study aims to enroll 80 participants, but its current status is unclear.

Study design

This interventional study plans to enroll 80 participants. It involves using either the Dexcom G6 device with real-time access to your glucose levels or a blinded Dexcom G6 sensor that provides glucose data after 10 days.

What's involved

You would need to wear the Dexcom G6 device at all times for the duration of the study. The primary endpoint, Time in Range, is measured at 70 days.

Compensation

Not stated in the trial record.

Follow-up

Your Time in Range (70-180 mg/dL) will be measured at 70 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.